Injectable peptide rapidly reduces intracranial pressure

A study for idiopathic intercranial hypertension is the first to show rapid and a major reduction in brain pressure and monthly headaches.

Related Keywords

United Kingdom ,Alex Sinclair ,Shelly Williamson ,Honorary Consultant Neurologist At University Hospitals Birmingham ,Institute Of Metabolism ,University Of Birmingham ,Systems Research ,Idiopathic Intercranial Hypertension ,Professor Alex Sinclair ,Honorary Consultant Neurologist ,University Hospitals Birmingham ,Principal Investigator ,Invex Therapeutics ,